CP
Chinese Peptide Company (CPC Scientific)
CDMO · Hangzhou, China
GMP
Overview
Chinese Peptide Company is a Hangzhou peptide contract research, development and manufacturing organization founded in 2001, with international headquarters in California and production bases in China and the USA. It is the cGMP plant of CPC Scientific, a subsidiary of Medtide Inc. It holds active US Type II DMFs for Cetrorelix, Semaglutide, Tirzepatide. In 2026 the Hangzhou plant completed a US FDA pre-license inspection for the Hepcludex API.
Capabilities
- Peptide CRDMO
- GMP peptide APIs
- Catalogue research peptides
- Oligonucleotide CDMO
- Regulatory filing support
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |